Frontlight ResearchEarly access
CompletedNo phase
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 19 people enrolled
- Started
- 16 Feb 2024
- Ended
- 27 Jun 2025
- Type of study
- Observational
- Treatments tested
- Patients with Anorexia Nervosa
- Record updated
- 17 April 2026
Who can take part
- Age
- 15 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patient over 15 years old
- Diagnosis of Restricted Eating Disorders including Anorexia Nervosa according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Admission to Nantes University Hospital
Who cannot take part
- Treatment with a drug known to induce fatty liver disease (amiodarone, carbamazepine, tamoxifen, valproate, clozapine, anti-retrovirals) unless the dose has been stable for ≥ 3 months
- Chronic active viral hepatitis
- Other genetic, autoimmune
- Hemochromatosis
- Excessive alcohol consumption (≥ 30 grams per day in men, ≥ 20 grams per day in women)
- Pregnant, parturient or breast-feeding women, persons deprived of liberty, adults under legal protection or unable to express their consent, persons not affiliated or not beneficiaries of a social security scheme, persons under guardianship or curators
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main goal of the BIocoLlection in Anorexia Nervosa-liver damage evaluation BILAN study the blood biomarkers associated with liver cytolysis.
Treatments tested
- Patients with Anorexia Nervosa
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- BILAN: Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood BIomarker ANaLysis
- Record updated
- 17 April 2026